Dr Gareth P Morgan FRSPH, Honorary Research Fellow at Cardiff University argues that everyone who has reached their half century could consider taking aspirin
Get full access to this article
View all access options for this article.
References
1.
Elwood PC, Morgan G., Brown G., Pickering J.Aspirin for everyone over 50?British Medical Journal2005; 330: 1440-1441
2.
Baigent C.Aspirin for everyone over 50?British Medical Journal2005; 330: 1442-1443
3.
Bulugahapitiya U., Siyambalapitiya S., Sithole J., Fernando DJ, Idris I.Age threshold for vascular prophylaxis by aspirin in patients without diabetes . Heart2008; 94: 1429-1432
4.
Morgan G.Aspirin for primary prevention of vascular events? Public Health2009; 12: 787-788
5.
Dalen JEAspirin for the primary prevention of stroke and myocardial infarction: Ineffective or wrong dose? American Journal of Medicine2010; 123: 101-102
6.
Aspirin for primary prevention of cardiovascular disease?Drugs and Therapeutic Bulletin2009; 47: 122-125
7.
Antithrombotic Trialists’ Collaboration.Aspirin in the primary prevention and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomized trials. Lancet2009; 373: 1849-1860
8.
Steering Committee of the Physicians’ Health Study Research Group.Final report of the aspirin component of the ongoing physicians’ health study. New England Journal of Medicine1989; 321: 129-135
9.
Flossman E., Rothwell PMEffect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomized and observational studies. Lancet2007; 369: 1603-1613
10.
Rothwell PM , Fowkes GR, Belch JFF, Ogawa H., Warlow CP, Meade TWEffect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet2011: 377: 31-41.
